Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN® [Phase 4]
Phase 4 trial comparing the efficacy and tolerability of TRAVATAN (travoprost) versus LUMIGAN (bimatoprost) in glaucoma and ocular hypertens…
-
FDA approval · 2015-07-10FDA Approved: TRAVOPROST — Original Application (Apotex Corp.)
The FDA approved Apotex Corp.'s original application for Travoprost, a generic eye drop used to lower intraocular pressure in glaucoma and o…
-
CLINICAL_TRIALS withdrawal · 2015-07-09Clinical Trial Update: The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface
A clinical trial evaluating the effect of omega-3 fatty acid supplementation on intraocular pressure and ocular surface in open-angle glauco…
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure [Phase 4]
Phase 4 clinical trial update assessing central corneal thickness and 24-hour intraocular pressure fluctuations in open angle glaucoma and o…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion. [Phase 1, Phase 2]
This clinical trial investigates whether magnetic therapy combined with seawater can reduce intraocular pressure in primary open-angle glauc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Survey of Patients Taking IOP-Lowering Eye Drops
Completed clinical trial update detailing a survey of patients taking intraocular pressure-lowering eye drops for glaucoma or ocular hyperte…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue [Phase 4]
Phase 4 clinical trial evaluating SIMBRINZA suspension as add-on therapy to a prostaglandin analogue in ocular hypertension and open-angle g…
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons
A completed clinical trial evaluating patients with primary open-angle glaucoma or ocular hypertension who switched to Lumigan UD monotherap…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: DE-111 Against Timolol Ophthalmic Solution 0.5% [Phase 3]
Phase 3 trial comparing DE-111 against Timolol ophthalmic solution 0.5% for open-angle glaucoma and ocular hypertension; results have been p…
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5% [Phase 3]
Phase 3 trial evaluating tafluprost 0.0015% alone and in combination with timolol 0.5% for open-angle glaucoma and ocular hypertension. Resu…
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial evaluating DE-111 ophthalmic solution for open-angle glaucoma or ocular hypertension has been completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z® [Phase 4]
Phase 4 clinical trial evaluating adding SIMBRINZA (brinzolamide and timolol) to TRAVATAN Z (travoprost) for ocular hypertension and open-an…
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) [Phase 3]
A Phase 3 trial comparing two glaucoma drugs over a 24-hour period has completed.
-
FDA approval · 2015-05-11FDA Approved: BETAXOLOL HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for betaxolol hydrochloride from Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 safety study of bimatoprost in patients with glaucoma or ocular hypertension has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-04-27Clinical Trial Update: An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments
An observational study assessing patients with primary open-angle glaucoma or ocular hypertension who switched IOP-lowering therapies; study…
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma [Phase 2]
A Phase 2 trial evaluating the hypotensive efficacy of AR-12286 ophthalmic solution (0.5% and 0.7%) in patients with Exfoliation Syndrome an…
-
CLINICAL_TRIALS trial_result · 2015-04-23Clinical Trial Update: An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More [Phase 4]
An open-label, non-randomized Phase 4 pilot study evaluated preservative-free tafluprost (Saflutan) in patients with ocular hypertension or …
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma [Phase 4]
A Phase 4 trial comparing two fixed-dose combination eye drops, DuoTrav (travoprost/timolol) and Xalacom (latanoprost/timolol), in open-angl…
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 4]
A Phase 4 trial evaluating intraocular pressure with Simbrinza in patients with open-angle glaucoma or ocular hypertension has completed, wi…
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers [Phase 1]
Phase 1 pharmacokinetic study of OPC-1085EL ophthalmic solution in healthy male volunteers has been completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: Ocular Hypertension Treatment Study (OHTS) [Phase 3]
Phase 3 clinical trial update for the Ocular Hypertension Treatment Study (OHTS) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Evaluation of Rate of Progression With Perimetry in Newly Diagnosed Open Angle Glaucoma
Clinical trial update evaluating the rate of progression in newly diagnosed open-angle glaucoma using perimetry, with ocular hypertension as…
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System [Phase 2]
Phase 2 safety extension study evaluating the biodegradation of the intravitreal Brimonidine tartrate Posterior Segment Drug Delivery System…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 study evaluating a fixed-combination bimatoprost and brimonidine for chronic glaucoma or ocular hypertension has completed, with res…